Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, Antagonists

Bibliographic Details
Main Author: Richard E Kast
Format: Article
Language:English
Published: Elsevier 2007-08-01
Series:Neoplasia: An International Journal for Oncology Research
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558607800765
_version_ 1828434811282259968
author Richard E Kast
author_facet Richard E Kast
author_sort Richard E Kast
collection DOAJ
first_indexed 2024-12-10T18:56:27Z
format Article
id doaj.art-d8d46598944b4fbdbfb47b43a5abd258
institution Directory Open Access Journal
issn 1476-5586
1522-8002
language English
last_indexed 2024-12-10T18:56:27Z
publishDate 2007-08-01
publisher Elsevier
record_format Article
series Neoplasia: An International Journal for Oncology Research
spelling doaj.art-d8d46598944b4fbdbfb47b43a5abd2582022-12-22T01:37:09ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022007-08-019868910.1593/neo.07451Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, AntagonistsRichard E Kasthttp://www.sciencedirect.com/science/article/pii/S1476558607800765
spellingShingle Richard E Kast
Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, Antagonists
Neoplasia: An International Journal for Oncology Research
title Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, Antagonists
title_full Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, Antagonists
title_fullStr Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, Antagonists
title_full_unstemmed Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, Antagonists
title_short Glioblastoma: Looking at the Currently Marketed Sigma-1 Agonists, Antagonists
title_sort glioblastoma looking at the currently marketed sigma 1 agonists antagonists
url http://www.sciencedirect.com/science/article/pii/S1476558607800765
work_keys_str_mv AT richardekast glioblastomalookingatthecurrentlymarketedsigma1agonistsantagonists